Lucinda Billingham

Biostatistician, vegetarian, runner

[OncoDaily @oncodaily]

🌟Lucinda Billingham Receives the 2025 @BTOGORG Lifetime Achievement Award🏆
@CindyBillingham

The British Thoracic Oncology Group (BTOG) has awarded Lucinda Billingham the 2025 BTOG Lifetime Achievement Award for her contributions to thoracic oncology in the UK.🫁 The award was presented by Professor Gary Middleton at the 23rd BTOG Annual Conference in Belfast.🎗️

💡This prestigious award recognizes individuals who have made a lasting impact on the field of thoracic oncology, shaping the future of cancer care and research. BTOG continues to honor those whose dedication has advanced the management of thoracic malignancies in the UK and beyond.🌍

https://t.co/prFL9POOhe

#Cancer #CancerResearch #BTOG2025 #Medicine #LungCancer #LCSM #MedX #MedEd #MedNews #Health #Oncology #OncoDaily

[Lucinda Billingham @CindyBillingham]

@BTOGORG So proud and amazed to have received this wonderful award from BTOG - huge thanks to Gary and to Sanjay and the BTOG Steering Committee for selecting me for this incredible honour

[BTOG @BTOGORG]

We are delighted to announce that the 2025 BTOG Lifetime Achievement Award has been presented to Professor @CindyBillingham.

The announcement was made by Professor Gary MIddleton with a heartfelt speech and hosted at the 23nd BTOG Annual Conference in Belfast by Professor @DrSanjayPopat. Professor Billingham received several well-deserved standing ovations.

Each year BTOG gives a lifetime achievement award to an individual who in the steering committee’s opinion has made a significant contribution to the management of thoracic malignancies in the UK.

#BTOG25 #LCSM

[College of Medicine and Health (UoB) @unibirm_CMH]

Welcome to Professor Amos Burke, who was recently appointed Director of the Birmingham Cancer Research UK Clinical Trials Unit @CRCTU @IcgsUob https://t.co/RS9AreMEfW https://t.co/c8eUoFiIgX

[College of Medicine and Health (UoB) @unibirm_CMH]

Prof @cindybillingham and @tori_homer, from @IcgsUob, tell us more about how the CAPTIVATE node is reimagining the way we design clinical trials for rare diseases, to enable results despite low numbers. Working with @sheffielduni & @LivUni and funded by @The_MRC & @NIHRresearch. https://t.co/9bEXaex6Yo

[College of Medicine and Health (UoB) @unibirm_CMH]

Prof @cindybillingham from @unibirmingham is leading the CAPTIVATE node, with colleagues from @sheffielduni & @LivUni. Reimagining how clinical trials for rare diseases are designed to enable results despite low numbers. Funded by @The_MRC & @NIHRresearch. https://t.co/RxU5aQqISG

[Birmingham Cancer Research UK Clinical Trials Unit @CRCTU]

Rhabdomyosarcoma is a soft tissue cancer that mostly affects young children. Collaboration in research is vital to save young lives. FaR-RMS trial is led by @JenneyMeriel and funded by @CRUKresearch #childhoodcancer #clinicaltrials

[Birmingham Cancer Research UK Clinical Trials Unit @CRCTU]

statistician Laura Kirton's excellent presentation of an innovative design tool to continuously monitor
efficacy outcomes in rare diseases
, such as #MonoGerm trial of carboplatin or vinblastine monotherapy in paediatric intracranial germinoma @CindyBillingham #ICTMC2022

[Lucinda Billingham @CindyBillingham]

Great talk from @StockenDeborah at #ICTMC2022 on In Silico Clinical Trials - definitely an interesting concept to take back to @CRCTU

[Rowena Sharpe @RoSharpe]

Our fantastic statistician Amit Patel presenting our ADePT DDR trial - wonderful example of innovative early phase trial design

[Rowena Sharpe @RoSharpe]

Our wonderful @CindyBillingham is presenting on the @CR_UK sponsored DETERMINE trial, with @CRUK_MI CI Matt Krebbs, @CRCTU methodology leadership and @unibirm_MDS translational leadership - wonderful example of collaboration

[Lucinda Billingham @CindyBillingham]

@DrGWheeler @ImperialSPH @stats_ci Belated Congratulations Graham - how exciting for you and Imperial CTU!

[Lucinda Billingham @CindyBillingham]

It is such a privilege to be Chief Biostatistician for #NationalLungMatrixTrial and so exciting to work with Trial Statistician Peter Fletcher @joyfeed and the brilliant national team of investigators led by Gary Middleton to deliver these first Bayesian results

[Birmingham Cancer Research UK Clinical Trials Unit @CRCTU]

today we have published the results of the ongoing #NationalLungMatrixTrial in @nature. A collaborative effort of @unibirmingham @cr_uk @AstraZeneca @pfizer to provide targeted treatments to 300+ lung cancer patients across 20+ NHS hospitals https://t.co/MWkxYCAq5F #NSCLC #NLMT

[Lucinda Billingham @CindyBillingham]

Great end to first day of the BTOG 2020 conference with John Humphrys hosting the debate about how to treat stage III NSCLC @BTOGORG @JohnHumphrysr4 #BTOG20

[Lucinda Billingham @CindyBillingham]

Sorry for wrong spelling! @JohnHumphrysr4

[Lucinda Billingham @CindyBillingham]

Very exciting to have John Humphries participating in our annual BTOG conference @BTOGORG #BTOG20

[Lucinda Billingham @CindyBillingham]

Birmingham's very own Prof Gary Middleton giving the BTOG community a rapid overview of lessons learned in the National Lung Matrix Trial @BTOGORG @CRCTU #BTOG20

[Lucinda Billingham @CindyBillingham]

Birmingham team successfully complete the #CTUBikeathon @CRUKBirmingham

[Lucinda Billingham @CindyBillingham]

Off to do the CRUK CTU bikeathon - check out the web page and any donations very welcome! #CTUBikeathon @CRUKBirmingham https:/fundraise.cancerresearchuk.org/unite/the-clinical-trials-bikeathon

[IASLC @IASLC]

Here are the first results of the National Lung Matrix Trial (NLMT), presented by Prof. Gary Middleton at the #WCLC19 symposium. Are some of these poor targets potentially good targets? @CR_UK #LCSM